Smith Sean Michael Insider Trades

Insider Trading History

Track insider trading activity for Smith Sean Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurogene
Neurogene NGNE
Interim Cfo, Prin Acct Off
Holding Value $595k 21,637 shares
Last Trade
Aug 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.4k 1,323 shares
$12.40
$27.48
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Interim Cfo, Prin Acct Off
Holding Value $75.5k 21,637 shares
Last Trade
Aug 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Interim Cfo, Prin Acct Off
Holding Value $631k 22,960 shares
Last Trade
Aug 10, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$63.2k 5,000 shares
$12.64
$27.48
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Interim Cfo, Prin Acct Off
Holding Value $0 0 shares
Last Trade
Aug 10, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Interim Cfo, Prin Acct Off
Holding Value $0 0 shares
Last Trade
Aug 10, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$63.2k 5,000 shares
$12.64
$27.48
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Interim Cfo, Prin Acct Off
Holding Value $80.1k 22,960 shares
Last Trade
Aug 10, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $55.7k 15,960 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Principal Accounting Officer
Holding Value $439k 15,960 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.4k 3,316 shares
$11.57
$27.48
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $67.3k 19,276 shares
Last Trade
Feb 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $43.6k 12,500 shares
Last Trade
Feb 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Principal Accounting Officer
Holding Value $530k 19,276 shares
Last Trade
Feb 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$148k 12,500 shares
$11.80
$27.48
Neurogene
Neurogene NGNE
Principal Accounting Officer
Holding Value $344k 12,500 shares
Last Trade
Feb 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$148k 12,500 shares
$11.80
$27.48
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $29.4k 8,431 shares
Last Trade
Aug 10, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $23.6k 6,776 shares
Last Trade
Aug 10, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $524k 150,000 shares
Last Trade
Aug 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $279k 80,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Principal Accounting Officer
Holding Value $12k 3,431 shares
Last Trade
Mar 02, 2022 Sale
No data
No data
$3.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up